Treatment Options - Proton Beam Brachytherapy

hormone Therapy

hormone Therapy for Prostate Cancer: What Patients Should Know

hormone therapy for prostate cancer is a treatment that lowers testosterone levels or blocks the effects of hormones that help prostate cancer grow. It is commonly used to treat advanced prostate cancer and may be combined with radiation therapy for certain patients with localized disease.

Although hormone therapy generally cannot cure prostate cancer on its own, it can slow cancer growth and improve treatment outcomes. Understanding how it works and when it’s recommended can help you make informed decisions with your healthcare team.

How Does hormone Therapy for Prostate Cancer Work?

testosterone and other male hormones, called androgens, play an important role in normal bodily functions. However, they can also stimulate the growth of prostate cancer cells.

Most prostate cancer cells have receptors that respond to androgens. When these hormones attach to the receptors, they can send signals that encourage cancer growth.

androgen deprivation therapy (ADT) limits these signals by substantially reducing testosterone production. Other hormone-related medications interfere with androgen receptors or block hormone production elsewhere in the body.

By limiting the effects of androgens, these treatments can help control prostate cancer, sometimes for extended periods.

What Are the Different Types of hormone Therapy for Prostate Cancer?

Several types of hormone therapy are available. Some reduce testosterone production, while others block its effects. The right approach depends on the cancer’s characteristics and what treatment is intended to accomplish.

LHRH/GnRH Agonists and Antagonists

These medications reduce testosterone production without surgery.

LHRH/GnRH agonists, such as leuprolide, initially cause a temporary rise in testosterone before lowering it. This increase, called a testosterone flare, can briefly worsen symptoms in some patients. Doctors may prescribe additional medication to prevent complications.

LHRH/GnRH antagonists, including degarelix and relugolix, lower testosterone more quickly without causing an initial flare.

These treatments are commonly administered through injections or, in the case of relugolix, daily oral medication.

Antiandrogens and androgen Receptor Inhibitors

Antiandrogens prevent testosterone and other androgens from stimulating prostate cancer cells.

Older medications, such as bicalutamide, block androgen receptors. Newer androgen receptor inhibitors, including enzalutamide, apalutamide, and darolutamide, interfere more extensively with androgen signaling.

Newer androgen receptor inhibitors are often combined with ADT for certain forms of advanced prostate cancer. Older antiandrogens may be used in other circumstances, including to help prevent testosterone flare when starting some ADT medications.

androgen Synthesis Inhibitors

androgen synthesis inhibitors reduce hormone production throughout the body.

Abiraterone, for example, blocks an enzyme involved in androgen production. It is generally prescribed with prednisone and used alongside treatment that suppresses testosterone production.

This approach may be recommended for certain patients with advanced or high-risk prostate cancer.

orchiectomy

orchiectomy is a surgical procedure that removes the testicles, where most testosterone is produced.

Unlike medication-based ADT, orchiectomy permanently lowers testosterone production. It is used less frequently in the United States because medications offer a nonsurgical alternative and may allow testosterone levels to recover after treatment ends.

When Is hormone Therapy Recommended for Prostate Cancer?

hormone therapy may be recommended at different stages of prostate cancer. The decision depends on the cancer’s characteristics, whether it has spread, and the patient’s overall health.

Localized prostate cancer: For patients with unfavorable intermediate-risk or high-risk disease, ADT may be combined with radiation therapy to improve treatment outcomes.

ADT may also be used before brachytherapy to reduce prostate size and make seed placement easier. In this situation, the goal is to prepare for the procedure rather than necessarily improve cancer control.

Advanced or Metastatic Prostate Cancer

When cancer has spread beyond the prostate, hormone therapy is a foundational treatment. Doctors often combine ADT with additional medications to improve disease control and survival.

Recurrent Prostate Cancer

hormone therapy may be considered when cancer returns after surgery or radiation. A rising prostate-specific antigen (PSA) level can indicate recurrence, but it doesn’t automatically mean ADT is necessary. Doctors consider how quickly PSA is increasing and other clinical factors before recommending treatment.

hormone therapy isn’t appropriate for every patient. Men with low-risk localized prostate cancer may be better candidates for active surveillance, depending on their individual circumstances.

How Effective Is hormone Therapy for Prostate Cancer?

Many patients respond well to hormone therapy, particularly when their cancer is sensitive to testosterone suppression. A falling PSA level is often an early sign that treatment is working.

For patients with certain localized cancers, adding ADT to radiation therapy can improve long-term cancer control and, in some circumstances, survival. In metastatic disease, combining ADT with newer medications has improved survival compared with ADT alone.

The benefits vary based on cancer stage and individual response. Understanding these potential outcomes, along with the effects treatment may have on daily life, is an important part of choosing a treatment plan.

Can Prostate Cancer Become Resistant to hormone Therapy?

Over time, some prostate cancers continue growing despite very low testosterone levels. This is known as castration-resistant prostate cancer.

Resistance is more common in advanced disease, although the time it takes to develop varies considerably.

Although the cancer may no longer respond adequately to testosterone suppression alone, additional treatments can help control the disease. Depending on the patient’s circumstances, doctors may recommend newer hormone-related medications, chemotherapy, or other therapies.

Doctors generally continue ADT while introducing additional treatments for castration-resistant prostate cancer.

What Are the Side Effects of hormone Therapy for Prostate Cancer?

hormone therapy affects more than cancer cells. Because testosterone supports several normal bodily functions, lowering its levels can cause physical and emotional changes.

Common side effects include hot flashes and fatigue. Many men also experience reduced sexual desire or erectile dysfunction.

Some patients notice weight gain or changes in body composition as muscle mass decreases. Mood changes and difficulty concentrating may also occur.

Long-term testosterone suppression can weaken bones, increasing the risk of osteoporosis and fractures. ADT may also contribute to insulin resistance and other metabolic changes.

Certain hormone treatments are associated with increased cardiovascular risks, particularly in patients with existing heart disease or other risk factors.

Not everyone experiences the same side effects. Their severity depends on the medications used, treatment duration, and individual health.

How Can Patients Manage hormone Therapy Side Effects?

Although some side effects are unavoidable, there are ways to protect your health and maintain your quality of life during treatment.

Stay physically active.

Regular exercise can help preserve muscle strength and improve energy levels. Resistance training and weight-bearing activities may also support bone health. Ask your healthcare team which activities are appropriate for you.

Protect your bones.

Your doctor may recommend bone density testing, particularly during long-term ADT. Calcium or vitamin D supplements may be appropriate depending on your individual needs.

Monitor your heart health.

Managing blood pressure, cholesterol, and blood sugar is especially important during treatment. Your care team can help you address existing cardiovascular risk factors.

Seek emotional support.

hormone therapy can affect your mood, relationships, and sense of well-being. Talking openly with your doctor or a counselor can help you manage these changes.

Support is also available through Wellness House’s prostate cancer programs, which offer exercise, nutrition guidance, emotional support, and caregiver resources for patients and families.

What Happens After hormone Therapy Ends?

For patients receiving temporary medication-based ADT, testosterone levels may gradually increase after treatment stops.

Recovery is often slower after longer treatment periods. Age and the specific medications used can also affect how quickly testosterone returns.

testosterone may recover within months for some men, while others experience prolonged suppression. Levels may not return to their previous range, particularly after extended treatment.

As hormone levels return, symptoms such as hot flashes and fatigue may improve. Sexual function can also recover, although some changes may persist.

Patients who undergo orchiectomy experience permanent testosterone suppression.

How Do Doctors Monitor hormone Therapy?

Regular follow-up appointments help doctors determine whether hormone therapy is controlling prostate cancer.

PSA testing is an important part of monitoring. Declining PSA levels often indicate a favorable response, while rising levels may prompt further evaluation.

Doctors may also measure testosterone to confirm that treatment is achieving adequate suppression.

Depending on your symptoms and test results, imaging or additional testing may be necessary.

Follow-up care also provides an opportunity to address side effects and monitor your overall health. Tell your doctor about new symptoms or changes that concern you.

Find Prostate Cancer Treatment Support in Chicago

A prostate cancer diagnosis can bring difficult decisions, particularly when you’re considering treatments that may affect your quality of life.

The Prostate Cancer Foundation of Chicago (PCFC) is committed to helping patients and families better understand their options and find support throughout their cancer journey.

PCFC hosts its own monthly prostate cancer support group at Wellness House in Hinsdale on the first Wednesday of each month, except in January and July. These meetings offer an opportunity to connect with others who understand the challenges of living with prostate cancer.

PCFC also helps fund Wellness House’s broader prostate cancer programs and sponsors a staff member dedicated to prostate cancer outreach.

Whether you’re beginning hormone therapy or adjusting to life after treatment, you and your family can find valuable resources through Wellness House’s prostate cancer programs.

Services include emotional support, exercise, nutrition guidance, and caregiver support.

You don’t have to navigate prostate cancer treatment alone. PCFC is here to help you find the information and local support you need.

Scroll to Top
Prostate Cancer Foundation of Chicago
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.